These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

684 related articles for article (PubMed ID: 15631107)

  • 21. Results of a standardised regimen for multidrug-resistant tuberculosis in Bangladesh.
    Van Deun A; Salim MA; Das AP; Bastian I; Portaels F
    Int J Tuberc Lung Dis; 2004 May; 8(5):560-7. PubMed ID: 15137531
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Tuberculosis treatment: dangerous regimens?
    Rieder HL; Arnadottir T; Trébucq A; Enarson DA
    Int J Tuberc Lung Dis; 2001 Jan; 5(1):1-3. PubMed ID: 11263509
    [No Abstract]   [Full Text] [Related]  

  • 23. [Rifampicin combined with ethambutol and other antitubercular drugs in the treatment of patients with pulmonary tuberculosis. Early results. I. Bacteriological evaluation].
    Masztalerz J
    Pneumonol Pol; 1976; 44(1):55-60. PubMed ID: 821043
    [No Abstract]   [Full Text] [Related]  

  • 24. Split-drug regimens for the treatment of patients with sputum smear-positive pulmonary tuberculosis--a unique approach.
    Santha T; Rehman F; Mitchison DA; Sarma GR; Reetha AM; Prabhaker R;
    Trop Med Int Health; 2004 May; 9(5):551-8. PubMed ID: 15117298
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Factors associated with treatment success for tuberculosis patients: a single center's experience in Turkey.
    Talay F; Kumbetli S; Altin S
    Jpn J Infect Dis; 2008 Jan; 61(1):25-30. PubMed ID: 18219130
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Treatment results of rifampicin (RFP) resistant isoniazid (INH) susceptible tuberculosis, a hospital based study].
    Yoshiyama T; Ogata H; Ito K; Aono A; Wada M
    Kekkaku; 2007 Feb; 82(2):95-101. PubMed ID: 17373318
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Drug-resistant tuberculosis of the brain in a two-year-old child.
    Mehta JB; Mejia E; Gallemore GH; Ramsey GF
    Tenn Med; 1998 Jul; 91(7):285-7. PubMed ID: 9659827
    [No Abstract]   [Full Text] [Related]  

  • 28. [Treatment of non-tuberculous pulmonary mycobacteriosis].
    Sakatani M; Nakajima Y
    Kekkaku; 2006 Jan; 81(1):35-50. PubMed ID: 16479999
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Efficacy of DOTS strategy in treatment of respiratory tuberculosis in Gorgan, Islamic Republic of Iran.
    Abassi A; Mansourian AR
    East Mediterr Health J; 2007; 13(3):664-9. PubMed ID: 17687840
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Representative drug susceptibility patterns for guiding design of re-treatment regimens for multidrug-resistant tuberculosis in Iran.
    Tabarsi P; Nooraki A; Mirsaeidi M; Amiri M; Baghaei P; Farnia P; Kazempour M; Heidarnazhad H; Alipanah N; Mansouri D; Masjedi MR
    Respirology; 2008 Jan; 13(1):108-11. PubMed ID: 18197919
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Problems about the management of active pulmonary tuberculosis patients undergoing haemodialysis--our experiences and nation-wide questionnaire survey].
    Tomioka H; Tada K; Ohyama A; Fujiyama R; Ohnishi H; Sakurai T; Sakamoto H; Nishiguchi H; Yamamoto T; Sakashita T; Shirai C; Iwasaki H
    Kekkaku; 2003 Apr; 78(4):353-8. PubMed ID: 12739395
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Factors associated with treatment outcomes in pulmonary tuberculosis in northeastern Thailand.
    Anunnatsiri S; Chetchotisakd P; Wanke C
    Southeast Asian J Trop Med Public Health; 2005 Mar; 36(2):324-30. PubMed ID: 15916037
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Process of acquiring drug resistance: retrospective review of records of MDR TB].
    Yoshiyama T; Ito K; Ogata H; Mitarai S; Hoshino H; Okumura M; Aman K; Aono A; Wada M
    Kekkaku; 2004 Dec; 79(12):717-24. PubMed ID: 15782617
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Mini epidemic of isoniazide resistant TB in rural TN: a need for supervised preventive therapy.
    Mehta J; Keith R; Al Hasan M; Ryland B; Roy T
    Tenn Med; 2009 Aug; 102(8):41-4. PubMed ID: 19691201
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [A case of pulmonary multiresistant Mycobacterium bovis tuberculosis in Madagascar].
    Ramarokoto H; Andrianasolo D; Rasolonavalona T; Ramaroson F; Razafitsiarovana I; Vincent V; Ratsimba L; Rasolofo Razanamparany V
    Arch Inst Pasteur Madagascar; 2003; 69(1-2):37-40. PubMed ID: 15678814
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Chemotherapy of tuberculosis--compliance, side effects and incidence of recurrence].
    Brändli O; Häcki MA; Scheel A; Stiefel M
    Schweiz Med Wochenschr; 1983 Jan; 113(3):92-6. PubMed ID: 6828844
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Impact of country of origin on drug-resistant tuberculosis among foreign-born persons in British Columbia.
    Moniruzzaman A; Elwood RK; Schulzer M; FitzGerald JM
    Int J Tuberc Lung Dis; 2006 Aug; 10(8):844-50. PubMed ID: 16898367
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Drug resistance profile of Mycobacterium tuberculosis isolates from pulmonary tuberculosis patients in Jos, Nigeria.
    Ani AE; Idoko J; Dalyop YB; Pitmang SL
    Trans R Soc Trop Med Hyg; 2009 Jan; 103(1):67-71. PubMed ID: 18789463
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Multidrug pulmonary tuberculosis: sociomedical features and the efficiency of inpatient treatment].
    Filiniuk OV; Ianova GV; Strelis AK; Urazova OI; Zemlianaia NA; Buĭnova LN; Voronkova OV; Ianov SA; Shchegertsov DIu
    Probl Tuberk Bolezn Legk; 2008; (8):23-8; discussion 28. PubMed ID: 18819334
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Tuberculosis drug resistance and treatment outcomes under DOTS settings in large cities in the Philippines.
    Ohkado A; Aguiman L; Adlawan S; Baring E; Quirante O; Suchi M; Endo S; Fujiki A; Mori T
    Int J Tuberc Lung Dis; 2006 Mar; 10(3):283-9. PubMed ID: 16562708
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 35.